HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N Ahmad Selected Research

silicon phthalocyanine

5/2001Involvement of Bcl-2 and Bax in photodynamic therapy-mediated apoptosis. Antisense Bcl-2 oligonucleotide sensitizes RIF 1 cells to photodynamic therapy apoptosis.
4/2001In vitro and in vivo inhibition of epidermal growth factor receptor-tyrosine kinase pathway by photodynamic therapy.
2/2001Recombinant human tumor necrosis factor alpha does not potentiate cell killing after photodynamic therapy with a silicon phthalocyanine in A431 human epidermoid carcinoma cells.
12/2000Involvement of Fas (APO-1/CD-95) during photodynamic-therapy-mediated apoptosis in human epidermoid carcinoma A431 cells.
11/2000Up-regulation of clusterin during phthalocyanine 4 photodynamic therapy-mediated apoptosis of tumor cells and ablation of mouse skin tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


N Ahmad Research Topics

Disease

23Neoplasms (Cancer)
01/2021 - 01/2000
9Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2001 - 04/2000
7Death (Near-Death Experience)
12/2010 - 12/2010
6Carcinogenesis
09/2001 - 01/2000
5Pain (Aches)
01/2017 - 01/2000
5Skin Neoplasms (Skin Cancer)
04/2001 - 01/2000
4Neoplasm Metastasis (Metastasis)
11/2020 - 02/2001
4Infections
10/2014 - 12/2005
3Delayed Graft Function
07/2015 - 12/2010
3Prostatic Neoplasms (Prostate Cancer)
08/2001 - 01/2000
3Carcinoma (Carcinomatosis)
02/2001 - 04/2000
2Body Weight (Weight, Body)
01/2022 - 01/2003
2Brain Death (Brain Dead)
11/2013 - 12/2010
2Renal Insufficiency (Renal Failure)
01/2013 - 05/2008
2Heart Arrest (Cardiac Arrest)
12/2010 - 06/2007
2Ischemia
11/2010 - 06/2007
2Fibrosarcoma
05/2001 - 11/2000
2Adenocarcinoma
02/2001 - 01/2000
1Weight Gain
01/2022
1Melioidosis
12/2021
1COVID-19
01/2021
1Lewis Lung Carcinoma
11/2020
1Temporomandibular Joint Disorders (Temporomandibular Joint Disorder)
01/2018
1Pulmonary Tuberculosis
01/2017
1Neuralgia (Stump Neuralgia)
01/2017
1Hyperalgesia
01/2017
1Tuberculosis (Tuberculoses)
01/2017
1Hyperthermia
12/2016
1Melanoma (Melanoma, Malignant)
10/2015
1Hereditary Nephritis (Alport Syndrome)
01/2015
1Dyspnea (Shortness of Breath)
01/2015
1Hemorrhage
01/2015
1Hemoptysis
01/2015
1Fever (Fevers)
01/2015
1Toxoplasmosis
12/2014
1Pathologic Constriction (Stenosis)
08/2014
1Hematologic Neoplasms (Hematological Malignancy)
04/2014
1Multiple Myeloma
04/2014
1Circulating Neoplastic Cells
04/2014
1Respiratory Tract Infections (Respiratory Tract Infection)
12/2013
1Thrombocytopenia (Thrombopenia)
01/2013
1POEMS Syndrome (Syndrome, POEMS)
01/2013
1Thrombotic Thrombocytopenic Purpura
01/2013

Drug/Important Bio-Agent (IBA)

9dicarboxydine (DCD)IBA
07/2015 - 12/2010
7TeaIBA
08/2001 - 01/2000
6Proteins (Proteins, Gene)FDA Link
01/2022 - 09/2000
6PolyphenolsIBA
08/2001 - 01/2000
51-phenyl-3,3-dimethyltriazene (PDT)IBA
05/2001 - 02/2000
5silicon phthalocyanineIBA
05/2001 - 11/2000
3Photosensitizing Agents (Photosensitizers)IBA
12/2016 - 02/2000
3Liposomes (Liposome)IBA
12/2016 - 05/2001
3AntioxidantsIBA
11/2001 - 01/2001
3CyclinsIBA
11/2001 - 04/2001
2Immunoglobulin M (IgM)IBA
12/2021 - 12/2014
2Pharmaceutical PreparationsIBA
01/2018 - 12/2016
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2018 - 12/2016
2Biomarkers (Surrogate Marker)IBA
04/2014 - 09/2000
2VaccinesIBA
10/2008 - 05/2001
2Cyclin-Dependent Kinases (cdk Proteins)IBA
11/2001 - 05/2001
2ResveratrolIBA
11/2001 - 05/2001
2Eflornithine (Ornidyl)FDA Link
09/2001 - 09/2000
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
02/2001 - 01/2000
2Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
02/2001 - 01/2000
2NF-kappa B (NF-kB)IBA
08/2000 - 04/2000
2epigallocatechin gallate (epigallocatechin-3-gallate)IBA
08/2000 - 04/2000
1Ether (Diethyl Ether)IBA
01/2022
1chromic oxideIBA
01/2022
1TicagrelorIBA
11/2020
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
11/2020
1Estrogens (Estrogen)FDA Link
01/2018
1Matrix Metalloproteinases (MMPs)IBA
01/2018
1Estrogen ReceptorsIBA
01/2018
1AcetoneIBA
01/2017
1Gabapentin (Neurontin)FDA LinkGeneric
01/2017
1Lipid Bilayers (Lipid Bilayer)IBA
12/2016
1temoporfinIBA
12/2016
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
10/2015
1Polo-Like Kinase 1IBA
10/2015
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
10/2015
1Mitogen-Activated Protein KinasesIBA
10/2015
1MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA
10/2015
1Sirolimus (Rapamycin)FDA Link
07/2015
1Alemtuzumab (Campath)FDA Link
01/2015
1Immunoglobulin G (IgG)IBA
12/2014
1AntibodiesIBA
12/2014
1Opioid Analgesics (Opioids)IBA
04/2014
1Meperidine (Pethidine)FDA LinkGeneric
04/2014
1MicroRNAs (MicroRNA)IBA
04/2014
1Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric
12/2013
1Trimethoprim (Proloprim)FDA LinkGeneric
12/2013
1SulfamethoxazoleFDA LinkGeneric
12/2013

Therapy/Procedure

13Therapeutics
01/2017 - 01/2000
9Kidney Transplantation
01/2015 - 11/2010
6Photochemotherapy (Photodynamic Therapy)
12/2016 - 02/2000
3Chemoprevention
03/2001 - 09/2000
2Transplantation
05/2008 - 06/2007
1Cochlear Implantation
01/2021
1Retreatment
01/2017
1Drug Therapy (Chemotherapy)
12/2016
1Stents
08/2014